Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Poster for New Osmium PS with Hypoxic Phototoxicity

<< Previous

Bullboard Posts

Next >>

Comment by gojotv!on Mar 03, 2021 1:06pm

175 Views

Post# 32705893

RE:Poster for New Osmium PS with Hypoxic Phototoxicity

So glad the news is getting out! When I had the pleasure of attending Dr. McFarland's last lecture at U.B.C., she talked about Rutherin-based PDC's, but forcussed more thoroughly on the (then) upcoming Osmium-based ones. She was proud to share preliminary findings that pointed to it being the PDC of choice for several anti-cancer applications,
Rutherrin and Os-04 provide a one-two punch against tumerous cancers. We're taking cancer to the mattresses, lol!
(Of course, if the general public understood the significance of this, the share price would soar, so start buying and hoarding, folks! We live in a world of science-deniers. Let their folly be our gain!)
GLTA real investors!